Literature DB >> 26220640

Advanced MR Imaging in Neuro-oncology.

A Radbruch1, M Bendszus2.   

Abstract

The value of magnetic resonance (MR) imaging for the clinical management of brain tumour patients has greatly increased in recent years through the introduction of functional MR sequences. Previously, MR imaging for brain tumours relied for the most part on contrast-enhanced T1-weighted MR sequences but today with the help of advanced functional MR sequences, the pathophysiological aspects of tumour growth can be directly visualised and investigated. This article will present the pathophysiological background of the MR sequences relevant to neuro-oncological imaging as well as potential clinical applications. Ultimately, we take a look at possible future developments for ultra-high-field MR imaging.

Entities:  

Keywords:  MR diffusion; MR perfusion; RANO criteria; Susceptibility weighted imaging

Mesh：

Year:  2015        PMID： 26220640     DOI： 10.1007/s00062-015-0439-2

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN： 1869-1439            Impact factor:   3.649


  50 in total

1.  Comment to: Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma: pitfalls in perfusion MRI in brain tumors : Tsien C, Galbán CJ, Chenevert TL, Johnson TD, Hamstra DA, Sundgren PC, Junck L, Meyer CR, Rehemtulla A, Lawrence T, Ross BD. J Clin Oncol. 2010;28:2293-9.

Authors:  A Radbruch; M Bendszus; W Wick; S Heiland
Journal:  Clin Neuroradiol       Date:  2010-08       Impact factor: 3.649

2.  Perfusion magnetic resonance imaging for parametric response maps in tumors: is it really that easy?

Authors:  Sabine Heiland; Wolfgang Wick; Martin Bendszus
Journal:  J Clin Oncol       Date:  2010-09-13       Impact factor: 44.544

3.  Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1999-01       Impact factor: 4.813

4.  Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.

Authors:  Whitney B Pope; Hyun J Kim; Jing Huo; Jeffry Alger; Matthew S Brown; David Gjertson; Victor Sai; Jonathan R Young; Leena Tekchandani; Timothy Cloughesy; Paul S Mischel; Albert Lai; Phioanh Nghiemphu; Syed Rahmanuddin; Jonathan Goldin
Journal:  Radiology       Date:  2009-07       Impact factor: 11.105

Review 5.  Pros and cons of current brain tumor imaging.

Authors:  Benjamin M Ellingson; Patrick Y Wen; Martin J van den Bent; Timothy F Cloughesy
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

6.  Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma.

Authors:  W B Pope; A Lai; R Mehta; H J Kim; J Qiao; J R Young; X Xue; J Goldin; M S Brown; P L Nghiemphu; A Tran; T F Cloughesy
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-17       Impact factor: 3.825

7.  Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas.

Authors:  Stella Blasel; Alina Jurcoane; Kea Franz; Gerald Morawe; Stefanie Pellikan; Elke Hattingen
Journal:  Acta Neurochir (Wien)       Date:  2010-08-27       Impact factor: 2.216

8.  Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma.

Authors:  R K Gupta; U Sinha; T F Cloughesy; J R Alger
Journal:  Magn Reson Med       Date:  1999-01       Impact factor: 4.668

9.  Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study.

Authors:  H S Kim; G-H Jahng; C W Ryu; S Y Kim
Journal:  AJNR Am J Neuroradiol       Date:  2009-05-20       Impact factor: 3.825

10.  Nuclear overhauser enhancement mediated chemical exchange saturation transfer imaging at 7 Tesla in glioblastoma patients.

Authors:  Daniel Paech; Moritz Zaiss; Jan-Eric Meissner; Johannes Windschuh; Benedikt Wiestler; Peter Bachert; Jan Oliver Neumann; Philipp Kickingereder; Heinz-Peter Schlemmer; Wolfgang Wick; Armin Michael Nagel; Sabine Heiland; Mark Edward Ladd; Martin Bendszus; Alexander Radbruch
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240
View more
  4 in total

Review 1.  Hyperpolarized carbon-13 magnetic resonance spectroscopic imaging: a clinical tool for studying tumour metabolism.

Authors:  Fulvio Zaccagna; James T Grist; Surrin S Deen; Ramona Woitek; Laura Mt Lechermann; Mary A McLean; Bristi Basu; Ferdia A Gallagher
Journal:  Br J Radiol       Date:  2018-01-19       Impact factor: 3.039

2.  Characterization of Skull Base Lesions Using Pseudo-Continuous Arterial Spin Labeling.

Authors:  B Geerts; D Leclercq; S Tezenas du Montcel; B Law-Ye; S Gerber; D Bernardeschi; D Galanaud; D Dormont; N Pyatigorskaya
Journal:  Clin Neuroradiol       Date:  2017-09-11       Impact factor: 3.649

Review 3.  Advanced MRI for Pediatric Brain Tumors with Emphasis on Clinical Benefits.

Authors:  Hyun Woo Goo; Young-Shin Ra
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

4.  Preoperative Metastatic Brain Tumor-Associated Intracerebral Hemorrhage Is Associated With Dismal Prognosis.

Authors:  Motaz Hamed; Niklas Schäfer; Christian Bode; Valeri Borger; Anna-Laura Potthoff; Lars Eichhorn; Frank A Giordano; Erdem Güresir; Muriel Heimann; Yon-Dschun Ko; Jennifer Landsberg; Felix Lehmann; Alexander Radbruch; Elisa Scharnböck; Christina Schaub; Katjana S Schwab; Johannes Weller; Ulrich Herrlinger; Hartmut Vatter; Patrick Schuss; Matthias Schneider
Journal:  Front Oncol       Date:  2021-09-14       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.